世界のペプチドベースのがん治療薬市場：市場規模・現状・予測

• 英文タイトル：Global Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7786 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、ペプチドベースのがん治療薬のグローバル市場について調査・分析したレポートで、種類別（ゴセレリン、ボルテゾミブ、ロイプロレリン、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・ペプチドベースのがん治療薬の世界市場規模 ・主要企業別市場シェア ・ペプチドベースのがん治療薬の世界市場規模：種類別（ゴセレリン、ボルテゾミブ、ロイプロレリン、その他） ・ペプチドベースのがん治療薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局） ・ペプチドベースのがん治療薬のアメリカ市場規模（種類別、用途別） ・ペプチドベースのがん治療薬のヨーロッパ市場規模（種類別、用途別） ・ペプチドベースのがん治療薬の中国市場規模（種類別、用途別） ・ペプチドベースのがん治療薬の日本市場規模（種類別、用途別） ・ペプチドベースのがん治療薬の東南アジア市場規模（種類別、用途別） ・ペプチドベースのがん治療薬のインド市場規模（種類別、用途別） ・ペプチドベースのがん治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・ペプチドベースのがん治療薬の世界市場予測（2019年-2025年） ・ペプチドベースのがん治療薬の地域別市場予測（2019年-2025年） ...

Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.In 2018, the global Peptide Based Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Peptide Based Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide Based Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study
Pfizer
AstraZeneca
Johnson & Johnson
Abbott Laboratories
Allergan
AbbVie
Bausch Health
Takeda Pharmaceutical

Market segment by Type, the product can be split into
Goserelin
Bortezomib
leuprorelin
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Peptide Based Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Peptide Based Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Peptide Based Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peptide Based Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Goserelin
1.4.3 Bortezomib
1.4.4 leuprorelin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Peptide Based Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Peptide Based Cancer Therapeutics Market Size
2.2 Peptide Based Cancer Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Peptide Based Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Peptide Based Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Peptide Based Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Peptide Based Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Peptide Based Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peptide Based Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Peptide Based Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Peptide Based Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Peptide Based Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Peptide Based Cancer Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Peptide Based Cancer Therapeutics Market Size (2014-2019)
5.2 Peptide Based Cancer Therapeutics Key Players in United States
5.3 United States Peptide Based Cancer Therapeutics Market Size by Type
5.4 United States Peptide Based Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Peptide Based Cancer Therapeutics Market Size (2014-2019)
6.2 Peptide Based Cancer Therapeutics Key Players in Europe
6.3 Europe Peptide Based Cancer Therapeutics Market Size by Type
6.4 Europe Peptide Based Cancer Therapeutics Market Size by Application

7 China
7.1 China Peptide Based Cancer Therapeutics Market Size (2014-2019)
7.2 Peptide Based Cancer Therapeutics Key Players in China
7.3 China Peptide Based Cancer Therapeutics Market Size by Type
7.4 China Peptide Based Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Peptide Based Cancer Therapeutics Market Size (2014-2019)
8.2 Peptide Based Cancer Therapeutics Key Players in Japan
8.3 Japan Peptide Based Cancer Therapeutics Market Size by Type
8.4 Japan Peptide Based Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Peptide Based Cancer Therapeutics Market Size (2014-2019)
9.2 Peptide Based Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Peptide Based Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Peptide Based Cancer Therapeutics Market Size by Application

10 India
10.1 India Peptide Based Cancer Therapeutics Market Size (2014-2019)
10.2 Peptide Based Cancer Therapeutics Key Players in India
10.3 India Peptide Based Cancer Therapeutics Market Size by Type
10.4 India Peptide Based Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Peptide Based Cancer Therapeutics Market Size (2014-2019)
11.2 Peptide Based Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Peptide Based Cancer Therapeutics Market Size by Type
11.4 Central & South America Peptide Based Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Peptide Based Cancer Therapeutics Introduction
12.1.4 Pfizer Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Peptide Based Cancer Therapeutics Introduction
12.2.4 AstraZeneca Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Peptide Based Cancer Therapeutics Introduction
12.3.4 Johnson & Johnson Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Peptide Based Cancer Therapeutics Introduction
12.4.4 Abbott Laboratories Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)
12.4.5 Abbott Laboratories Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Peptide Based Cancer Therapeutics Introduction
12.5.4 Allergan Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)
12.5.5 Allergan Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Peptide Based Cancer Therapeutics Introduction
12.6.4 AbbVie Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Bausch Health
12.7.1 Bausch Health Company Details
12.7.2 Company Description and Business Overview
12.7.3 Peptide Based Cancer Therapeutics Introduction
12.7.4 Bausch Health Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)
12.7.5 Bausch Health Recent Development
12.8 Takeda Pharmaceutical
12.8.1 Takeda Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Peptide Based Cancer Therapeutics Introduction
12.8.4 Takeda Pharmaceutical Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)
12.8.5 Takeda Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Peptide Based Cancer Therapeutics Key Market Segments
Table Key Players Peptide Based Cancer Therapeutics Covered
Table Global Peptide Based Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Peptide Based Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Goserelin Figures
Table Key Players of Goserelin
Figure Bortezomib Figures
Table Key Players of Bortezomib
Figure leuprorelin Figures
Table Key Players of leuprorelin
Figure Others Figures
Table Key Players of Others
Table Global Peptide Based Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Peptide Based Cancer Therapeutics Report Years Considered
Table Global Peptide Based Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Peptide Based Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Peptide Based Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Peptide Based Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Peptide Based Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Peptide Based Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Peptide Based Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Peptide Based Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Peptide Based Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Peptide Based Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Peptide Based Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Peptide Based Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Peptide Based Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Peptide Based Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Peptide Based Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Peptide Based Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Peptide Based Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Peptide Based Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Peptide Based Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Peptide Based Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Peptide Based Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Peptide Based Cancer Therapeutics Market Share (2018-2019)
Table United States Peptide Based Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Peptide Based Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Peptide Based Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Peptide Based Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Peptide Based Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Peptide Based Cancer Therapeutics Market Share (2018-2019)
Table Europe Peptide Based Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Peptide Based Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Peptide Based Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Peptide Based Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Peptide Based Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Peptide Based Cancer Therapeutics Market Share (2018-2019)
Table China Peptide Based Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Peptide Based Cancer Therapeutics Market Share by Type (2014-2019)
Table China Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Peptide Based Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Peptide Based Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Peptide Based Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Peptide Based Cancer Therapeutics Market Share (2018-2019)
Table Japan Peptide Based Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Peptide Based Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Peptide Based Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Peptide Based Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Peptide Based Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Peptide Based Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Peptide Based Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Peptide Based Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Peptide Based Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Peptide Based Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Peptide Based Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Peptide Based Cancer Therapeutics Market Share (2018-2019)
Table India Peptide Based Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Peptide Based Cancer Therapeutics Market Share by Type (2014-2019)
Table India Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Peptide Based Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Peptide Based Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Peptide Based Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Peptide Based Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Peptide Based Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Peptide Based Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Peptide Based Cancer Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Peptide Based Cancer Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Allergan Company Details
Table Allergan Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2014-2019)
Table AbbVie Recent Development
Table Bausch Health Company Details
Table Bausch Health Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Bausch Health Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2014-2019)
Table Bausch Health Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Peptide Based Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Global Peptide Based Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Peptide Based Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Peptide Based Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Peptide Based Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Peptide Based Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Peptide Based Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Peptide Based Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Peptide Based Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Peptide Based Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Peptide Based Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Peptide Based Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Peptide Based Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Peptide Based Cancer Therapeutics Market Size by Product in 2025
Table Global Peptide Based Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Peptide Based Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Peptide Based Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---